This inventor holds 1 USPTO granted patent. Top assignee: Cz Biohub Sf, LLC.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovator Spotlight: Jenai Quan
Introduction
Jenai Quan, an inventive mind based in San Francisco, CA, has made significant strides in the field of biotechnology. With a strong focus on nucleic acid research, Jenai has developed innovative methods that enhance the analysis of genetic materials. His contributions in this domain are exemplified by his patent, which showcases his commitment to advancing scientific knowledge.
Latest Patents
Jenai holds a patent for a method titled "Nucleic acid sequence enrichment by defined nucleic acid-directed endonuclease digestion." This innovative process involves providing a sample of end-blocked polynucleotides and digesting it with specific nucleic acid-directed endonucleases that target sequences of interest. The method produces a digested sample consisting of polynucleotide fragments, which are then enriched to exceed their relative abundance in the original sample by significant margins—greater than 55 times or even 750 times. This patent not only reflects his ingenuity but also represents a crucial advancement in sample analysis techniques.
Career Highlights
Jenai is affiliated with Cz Biohub SF, LLC, where he collaborates with fellow researchers and professionals to explore new frontiers in biotechnology. His work at this organization has solidified his reputation as a promising inventor in the scientific community. The application of his patented method could revolutionize research in genetics, providing scientists with invaluable tools for studying complex biological questions.
Collaborations
In his role, Jenai has had the pleasure of working alongside talented individuals, including Emily D. Crawford, who also contributes significantly to the team's endeavors. Their collaboration exemplifies the spirit of innovation and teamwork that drives progress in research institutions like Cz Biohub SF.
Conclusion
Jenai Quan's contributions to the realm of biotechnology, notably through his patented method for nucleic acid analysis, underscore his role as a leading inventor in the industry. With his expertise and collaborative spirit, Jenai continues to push the boundaries of scientific research, inspiring future innovations in the field. His journey is a testament to the profound impact that dedicated inventors can have on advancing technology and medicine.